ResearcherNo recent work listed

Wenting Wang

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-8344-0102; OpenAlex author ID A5100361560.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

Somatostatin Inhibited the EMT of Pancreatic Cancer Cells by Mediating the TGF-β/Smad Signaling Pathway. Co-author DOI 10.24976/discov.med.202335179.105 ↗
Prognostic value of eight immune gene signatures in pancreatic cancer patients. First author DOI 10.1186/s12920-020-00868-w ↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

L.-Z. Liu · 1 shared paper, 2023
- Paper Somatostatin Inhibited the EMT of Pancreatic Cancer Cells by Mediating the TGF-β/Smad Signaling Pathway. DOI 10.24976/discov.med.202335179.105 ↗
Xuan Zhou · 1 shared paper, 2023
- Paper Somatostatin Inhibited the EMT of Pancreatic Cancer Cells by Mediating the TGF-β/Smad Signaling Pathway. DOI 10.24976/discov.med.202335179.105 ↗
Hao Lin · 1 shared paper, 2021
- Paper Prognostic value of eight immune gene signatures in pancreatic cancer patients. DOI 10.1186/s12920-020-00868-w ↗
Lu Yue · 1 shared paper, 2021
- Paper Prognostic value of eight immune gene signatures in pancreatic cancer patients. DOI 10.1186/s12920-020-00868-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.